| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016065 |
| Receipt No. | R000018595 |
| Scientific Title | A pilot study for evaluating hypoxia area in pancreas cancer by 18F-FMISO PET/CT |
| Date of disclosure of the study information | 2015/01/01 |
| Last modified on | 2020/03/17 (Ver. 2) |
| Basic information | ||
| Public title | A pilot study for evaluating hypoxia area in pancreas cancer by 18F-FMISO PET/CT | |
| Acronym | A pilot study for pancreas cancer by FMISO-PET/CT | |
| Scientific Title | A pilot study for evaluating hypoxia area in pancreas cancer by 18F-FMISO PET/CT | |
| Scientific Title:Acronym | A pilot study for pancreas cancer by FMISO-PET/CT | |
| Region |
|
|
| Condition | |||||
| Condition | Pancreas cancer | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To evaluate the clinical efficiency of 18F-FDG-PET for the patients with pancreas cancer |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To evaluate the acquisition protocol of 18F-FMISO-PET/CT for pancreas cancer
To compare the result of 18F-FMISO-PET/CT with the other imaging modalities To compare the result of 18F-FMISO-PET/CT with the clinical outcome |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Diagnosis | ||
| Type of intervention |
|
||
| Interventions/Control_1 | 18F-FMISO-PET/CT | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with written informed consent
2) Patients who were diagnosed or suspected as pancreas cancer 3) Patients who have already acquired or were planned to acquire 18F-FDG-PET/CT |
|||
| Key exclusion criteria | 1) Patients with pregnancy or possibility of pregnancy
2) Patients who cannot keep supine position during the PET exam of approximately 30 minutes 3) Patients who were considered to be inappropriate to join this study |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Saitama International Medical Center, Saitama Medical University | ||||||
| Division name | Department of Nuclear Medicine | ||||||
| Zip code | |||||||
| Address | 1397-1, Yamane, Hidaka, Saitama | ||||||
| TEL | 042-984-4111 | ||||||
| t_yamane@saitama-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Saitama International Medical Center, Saitama Medical University | ||||||
| Division name | Department of Nuclear Medicine | ||||||
| Zip code | |||||||
| Address | 1397-1, Yamane, Hidaka, Saitama | ||||||
| TEL | 042-984-4111 | ||||||
| Homepage URL | |||||||
| t_yamane@saitama-med.ac.jp | |||||||
| Sponsor | |
| Institute | Saitama International Medical Center, Saitama Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saitama International Medical Center, Saitama Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 埼玉医科大学国際医療センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018595 |